MedPath

Yong Zhang MD

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Neoadjuvant Chemotherapy With PD-1 Inhibitors Combined With SIB-IMRT in the Treatment of Locally Advanced Rectal Cancer

Phase 3
Recruiting
Conditions
Rectal Neoplasms
Interventions
First Posted Date
2023-08-30
Last Posted Date
2023-10-11
Lead Sponsor
Yong Zhang,MD
Target Recruit Count
48
Registration Number
NCT06017583
Locations
🇨🇳

First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China

Tislelizumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer

Phase 2
Recruiting
Conditions
Uterine Cervical Neoplasms
Interventions
First Posted Date
2022-10-20
Last Posted Date
2023-11-24
Lead Sponsor
Yong Zhang,MD
Target Recruit Count
30
Registration Number
NCT05588219
Locations
🇨🇳

First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China

Endostar Combined With Concurrent Chemoradiotherapy For Locally Advanced Cervical Carcinoma

Phase 3
Conditions
Cervical Carcinoma
Interventions
First Posted Date
2017-03-22
Last Posted Date
2017-03-22
Lead Sponsor
Yong Zhang,MD
Target Recruit Count
120
Registration Number
NCT03086681
Locations
🇨🇳

First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China

© Copyright 2025. All Rights Reserved by MedPath